• There is evidence that the abnormalities in hypothalamicpituitary-adrenal (HPA) axis function observed in patients with depression may be related to changes in central neurotransmitter receptor function. To evaluate this possibility further, the α2-adrenergic receptor antagonist yohimbine hydrochloride, which increases brain norepinephrine turnover, was administered to 40 patients with DSM-III major depression (18 melancholic, 22 nonmelancholic) and 16 healthy controls. Plasma free 3-methoxy-4-hydroxyphenylglycol (MHPG) level was measured as an index of noradrenergic function, and plasma cortisol level was used to assess the HPA response. Baseline cortisol levels were elevated in melancholic depressed patients, but not in nonmelancholic patients, when compared with healthy controls. The cortisol response to yohimbine was significantly greater in depressed patients than in controls, despite similar MHPG responses between groups. Since there is evidence that stimulation of postsynaptic α2-adrenergic receptors inhibits HPA axis function, the abnormally increased cortisol response to the α2-antagonist yohimbine suggests a relative subsensitivity of postsynaptic α2-adrenergic receptors in depression.
Price LH, Charney DS, Rubin AL, Heninger GR. α2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine. Arch Gen Psychiatry. 1986;43(9):849–858. doi:10.1001/archpsyc.1986.01800090035006
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: